Previous studies have shown that aluminum inhibits vitamin D-dependent calcium absorption. The mechanism involves reduced sensitivity to 1,25-dihydroxycholecalciferol and reduced expression of the calcium transport protein, calbindin-D28k. Reduced expression of calbindin protein may be due to decreased levels of calbindin mRNA. To test this hypothesis, we measured calbindin mRNA levels in chicks fed diets with and without added aluminum. Groups of chicks were fed one of four diets: control, control plus aluminum, low calcium, or low calcium plus aluminum. A fifth group was fed a vitamin D-free diet as a negative control. Calbindin protein was measured by immunoblotting. Serum calcium and inorganic phosphorus were determined. Intestinal mRNA was isolated and assayed by slot-blot hybridization to a fluorescein-conjugated oligonucleotide probe complementary to calbindin-D28k mRNA. Antifluorescein antibodies conjugated to alkaline phosphatase were used to detect hybrids and mRNA levels were quantified by densitometry. Specificity of the probe was verified by Northern analysis. Intestinal calbindin protein was greater in the control plus aluminum group than in controls, but no difference in calbindin mRNA was observed. These changes were associated with small decreases in serum phosphorus and calcium, suggesting a postranscriptional effect of aluminum. Chicks fed the low calcium diet had greater intestinal calbindin protein and mRNA levels relative to the control group in association with a 45% decrease in serum calcium. In contrast, no difference in calbindin protein, and significantly less mRNA were found in the low calcium plus aluminum group compared with controls, despite a decrease in serum calcium similar to that of chicks fed the low calcium diet without aluminum. These results show that in chicks fed a low calcium diet, aluminum intake decreases transcription and/or stability of intestinal calbindin mRNA, and that aluminum may inhibit the expression of vitamin D-dependent genes. J. Nutr. 131: 2007Nutr. 131: -2013Nutr. 131: , 2001.Aluminum can accumulate in the body whenever uptake exceeds the disposal of this metal via urinary or biliary excretion (1). Toxic accumulation most often occurs from large oral intakes, contaminated parenteral solutions or in individuals with renal insufficiency. Aluminum toxicity has been clearly demonstrated in patients with renal failure (2). It has also been reported in preterm infants fed intravenously (3), healthy premature infants (4), healthy adults chronically consuming aluminum containing antacids and their offspring (5,6).The symptoms of aluminum toxicity include neurodegenerative disorders, mycrocytic anemia unresponsive to iron and bone disease (vitamin D-resistant osteomalasia). The molecular mechanisms causing these symptoms are not well understood. Many biochemical processes have been shown to be affected by aluminum, but there is little agreement as to which are relevant to its toxic effects. Some proposed mechanisms include disrupting membrane function,...